Cargando…
Anti-PD-1 therapy for clinical treatment of lymphoma: a single-arm meta-analysis
Anti-PD1 antibodies exhibit satisfactory efficacy in treating certain types of lymphoma. We conducted this meta-analysis to explore subtypes benefiting from this treatment and the best anti-PD1 therapeutic modalities. METHODS: A quantitative meta-analysis was performed via a systematic search in Pub...
Autores principales: | Geng, Zhe, Xiao, Yi, Zhu, Xiao-Jian, Ye, Cong, Zhou, Jian-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219677/ https://www.ncbi.nlm.nih.gov/pubmed/30450162 http://dx.doi.org/10.18632/oncotarget.26223 |
Ejemplares similares
-
Efficacy and safety of anti-PD-1/anti-PD-L1 antibody therapy in treatment of advanced gastric cancer or gastroesophageal junction cancer: A meta-analysis
por: Yang, Li, et al.
Publicado: (2020) -
The efficacy and safety of anti-PD-1/PD-L1 antibody therapy versus docetaxel for pretreated advanced NSCLC: a meta-analysis
por: Huang, Guanghong, et al.
Publicado: (2017) -
Effectiveness of anti-PD-1/PD-L1 antibodies in urothelial carcinoma patients with different PD-L1 expression levels: a meta-analysis
por: Liu, Junqi, et al.
Publicado: (2018) -
Maintenance therapy for untreated diffuse large B-cell lymphoma: a systematic review and network meta-analysis
por: Yuan, Ting, et al.
Publicado: (2021) -
Rectal nonsteroidal anti-inflammatory drugs, glyceryl trinitrate, or combinations for prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: A network meta-analysis
por: Shi, Qing-Qing, et al.
Publicado: (2022)